Literature DB >> 3024595

Pylorus-preserving pancreatoduodenectomy. A clinical and physiologic appraisal.

K M Itani, R E Coleman, W C Meyers, O E Akwari.   

Abstract

Since 1978, 252 patients from different centers in the world have undergone pylorus-preserving pancreatoduodenectomy. Fifty-five per cent of the patients had malignant tumors in the region of the head of the pancreas. The overall operative mortality rate was 2.8%. Anastomotic leakage and fistulae occurred in 19% of the patients. Pancreatic, biliary, and enteric fistulae represented 11%, 4%, and 4%, respectively. Peptic ulcers were subsequently diagnosed in seven patients (3%), two of whom required vagotomy and antrectomy. Delayed recovery of gastric function was the most common complication of this operation, with an overall incidence of 30%. Although the cause of this gastric dysfunction is unknown, its transient nature in most patients makes expectant therapy with gastric tube drainage the best remedy when the problem is encountered. Pylorus-preserving pancreatoduodenectomy decreased the incidence of postgastric surgery syndromes that are commonly associated with the standard Whipple operation. The existing data support the continued use of the operation and the need for future laboratory and clinical investigation of its physiologic impact.

Entities:  

Mesh:

Year:  1986        PMID: 3024595      PMCID: PMC1251421          DOI: 10.1097/00000658-198612000-00007

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  42 in total

1.  Pancreatoduodenectomy for periampullary cancer.

Authors:  K W Warren; M C Veidenheimer; H S Pratt
Journal:  Surg Clin North Am       Date:  1967-06       Impact factor: 2.741

2.  Pyloric-sphincter dysfunction in patients with gastric ulcer.

Authors:  R S Fisher; S Cohen
Journal:  N Engl J Med       Date:  1973-02-08       Impact factor: 91.245

3.  Localization of the duodenal pacemaker and its role in the organization of duodenal myoelectric activity.

Authors:  J Hermon-Taylor; C F Code
Journal:  Gut       Date:  1971-01       Impact factor: 23.059

4.  [Pylorus preservation in pancreatoduodenectomy].

Authors:  A Baltasar; J Tomás; J Miralles
Journal:  Rev Esp Enferm Apar Dig       Date:  1983-06

5.  Electric pacing of intact and transected canine small intestine and its computer model.

Authors:  O E Akwari; K A Kelley; J H Steinbach; C F Code
Journal:  Am J Physiol       Date:  1975-11

6.  [A new concept in the surgery of chronic pancreatitis (author's transl)].

Authors:  F P Gall; C Gebhardt
Journal:  Dtsch Med Wochenschr       Date:  1979-07-13       Impact factor: 0.628

7.  beta-Endorphin in the human pancreas.

Authors:  J F Bruni; W B Watkins; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1979-10       Impact factor: 5.958

8.  Leiomyosarcoma of the small and large bowel.

Authors:  O E Akwari; R R Dozois; L H Weiland; O H Beahrs
Journal:  Cancer       Date:  1978-09       Impact factor: 6.860

9.  Pancreatic cancer: approach to diagnosis, selection for surgery and choice of operation.

Authors:  A R Moossa
Journal:  Cancer       Date:  1982-12-01       Impact factor: 6.860

10.  Preservation of the pylorus in pancreaticoduodenectomy a follow-up evaluation.

Authors:  L W Traverso; W P Longmire
Journal:  Ann Surg       Date:  1980-09       Impact factor: 12.969

View more
  58 in total

1.  Gastric phase 3 motility after pylorus-preserving pancreatoduodenectomy.

Authors:  Takao Ohtsuka; Shunichi Takahata; Jiro Ohuchida; Torahiko Takeda; Hiroaki Matsunaga; Kazunori Yokohata; Koji Yamaguchi; Kazuo Chijiiwa; Masao Tanaka
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

2.  Pylorus-preserving duodenopancreatectomy: long-term complications and comparison with the Whipple procedure.

Authors:  P Morel; P Mathey; H Corboud; O Huber; R A Egeli; A Rohner
Journal:  World J Surg       Date:  1990 Sep-Oct       Impact factor: 3.352

Review 3.  Pylorus-preserving pancreatoduodenectomy--technical aspects.

Authors:  J W Braasch; M Gagner
Journal:  Langenbecks Arch Chir       Date:  1991

Review 4.  Delayed gastric emptying is associated with pylorus-preserving but not classical Whipple pancreaticoduodenectomy: a review of the literature and critical reappraisal of the implicated pathomechanism.

Authors:  Kosmas I Paraskevas; Costas Avgerinos; Costas Manes; Dimitris Lytras; Christos Dervenis
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

Review 5.  Therapeutic strategies for the management of delayed gastric emptying after pancreatic resection.

Authors:  Dimitrios Lytras; Kosmas I Paraskevas; Costas Avgerinos; Costas Manes; Zisis Touloumis; Konstantina D Paraskeva; Christos Dervenis
Journal:  Langenbecks Arch Surg       Date:  2006-10-05       Impact factor: 3.445

6.  Factors influencing clinically significant delayed gastric emptying after subtotal stomach-preserving pancreatoduodenectomy.

Authors:  Go Sato; Yoichi Ishizaki; Jiro Yoshimoto; Hiroyuki Sugo; Hiroshi Imamura; Seiji Kawasaki
Journal:  World J Surg       Date:  2014-04       Impact factor: 3.352

7.  Subtotal pancreatectomy with stapling the pancreatic remnant.

Authors:  B Ahrén; S Bengmark
Journal:  Langenbecks Arch Chir       Date:  1990

8.  Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short-term results.

Authors:  K E Bakkevold; B Kambestad
Journal:  Ann Surg       Date:  1993-04       Impact factor: 12.969

9.  Delayed gastric emptying after pylorus-preserving pancreatoduodenectomy is strongly related to other postoperative complications.

Authors:  Hartwig Riediger; Frank Makowiec; Wolfgang D Schareck; Ulrich T Hopt; Ulrich Adam
Journal:  J Gastrointest Surg       Date:  2003 Sep-Oct       Impact factor: 3.452

10.  Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trial.

Authors:  C J Yeo; M K Barry; P K Sauter; S Sostre; K D Lillemoe; H A Pitt; J L Cameron
Journal:  Ann Surg       Date:  1993-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.